tiprankstipranks
Trending News
More News >
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market

VYNE Therapeutics (VYNE) Revenue

Compare
1,901 Followers

VYNE Therapeutics Revenue

VYNE Therapeutics had a revenue of 130.00K in the quarter ending Dec 31, 2025, with -23.08%. This bring the company's revenue in the last twelve months to 570.00K, Decreased 8.78%. In the fiscal year ending Dec 31, 2025, VYNE Therapeutics had annual revenue of 570.00K with 13.77% growth.
Revenue (ttm)
570.00K
Revenue Growth
6.29%
P/S Ratio
34.18
Revenue/Employee
$43,846
Employees
13
Market Cap
$19.48M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
570.00K69.00K+13.77%
Dec 31, 2024
501.00K77.00K+18.16%
Dec 31, 2023
424.00K-53.00K-11.11%
Dec 31, 2022
477.00K-454.00K-48.76%
Dec 31, 2021
931.00K-20.06M-95.57%
Dec 31, 2020
20.99M20.55M+4,638.83%
Dec 31, 2019
443.00K-10.20M-95.84%
Dec 31, 2018
10.64M6.06M+132.21%
Dec 31, 2017
4.58M